English | Español
Patient Daily | Apr 10, 2026

FDA expected to make key drug approval decisions in second quarter of 2026
Patient Daily | Apr 10, 2026

Kevin Tang returns as Aurinia CEO with $50 million offer for Kezar Life Sciences
Patient Daily | Apr 10, 2026

Study shows PSMA therapy can delay hormone treatment in prostate cancer patients
Patient Daily | Apr 10, 2026

Study finds inhaling disinfectant chemicals may cause lung injury in mice
Patient Daily | Apr 10, 2026

Ochsner Health holds community health fair in Iberville Parish for cancer awareness
Patient Daily | Apr 10, 2026

Study finds ALDH2 inhibition targets APC-deficient colorectal cancer cells
Patient Daily | Apr 10, 2026

Study links atrial fibrillation to poorer brain clearance and cognitive decline
Patient Daily | Apr 10, 2026

American Heart Association and Additional Ventures commit $20 million to Fontan care initiative

Trending
+ Regulatory
Patient Daily | Jun 16, 2026

PhRMA official: 'A program meant to help vulnerable patients shouldn't be treated like a business strategy'
+ Regulatory
A. R. Baird | Jun 15, 2026

Health care reform group launches campaign linking consolidation to rising costs
+ Pharmaceuticals
Patient Daily | Jun 16, 2026

Intellia gene editing therapy shows strong results in hereditary angioedema study
+ Pharmaceuticals
Patient Daily | Jun 17, 2026

PwC reports strong biopharma M&A activity as sector shifts to precision science